Technical Analysis for VRPX - Virpax Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 5.39 -4.09% -0.23
VRPX closed down 4.09 percent on Friday, February 26, 2021, on 34 percent of normal volume. The bears made the stock sink to a new 52-week low.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A N/A
Historical VRPX trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
New 52 Week Low Weakness 0.00%
New 52 Week Closing Low Bearish -4.09%
New 52 Week Closing Low Bearish -6.26%
Hot IPO Pullback Bullish Swing Setup -6.26%
New 52 Week Low Weakness -6.26%
Gapped Down Weakness -6.26%
Hot IPO Pullback Bullish Swing Setup -12.21%
Outside Day Range Expansion -12.21%
Hot IPO Pullback Bullish Swing Setup -13.90%
Older End-of-Day Signals for VRPX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Virpax Pharmaceuticals, Inc. Description

Virpax Pharmaceuticals, Inc. develops and manufactures non-opioid and non-addictive based drug compounds and drug delivery systems for pain management. It offers products, such as Probudur, an injectable bupivacaine hydrogel for postoperative pain management; Epoladerm, a diclofenac metered-dose spray film for acute musculoskeletal pain; and NES100, an endogenous enkephalin intranasal spray for acute and chronic spray. The company develops drug delivery technologies, such as Topical metered-dose spray, Liposomal in Hydrogel encapsulation, and Enkephalin Intranasal spray. It also develops therapies to manage post-traumatic stress disorder (PTSD), as well as to help prevent viral spread, including influenza and SARS-CoV-2 (Covid-19). Virpax Pharmaceuticals, Inc. was founded in 2016 and is based in Malvern, Pennsylvania.


Classification

Keywords: Pain Drugs Health Sciences Influenza Drug Delivery Pain Management Dosage Forms Euphoriants Analgesics Morphinans Opioids Bupivacaine Drug Delivery Systems Heroin Drug Delivery Technologies Post Traumatic Stress Disorder Morphine

Is VRPX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.24
52 Week Low 5.25
Average Volume 216,889
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 0.00
10-Day Moving Average 0.00
Average True Range 0.00
ADX 0.0
+DI 0.00
-DI 0.00
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.00
Lower Bollinger Band 0.00
Percent B (%b) 0.0
BandWidth 0.00
MACD Line 0.00
MACD Signal Line 0.00
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.22
Resistance 3 (R3) 6.26 6.03 6.08
Resistance 2 (R2) 6.03 5.82 6.01 6.03
Resistance 1 (R1) 5.71 5.69 5.60 5.67 5.99
Pivot Point 5.48 5.48 5.42 5.46 5.48
Support 1 (S1) 5.16 5.27 5.05 5.12 4.79
Support 2 (S2) 4.93 5.14 4.91 4.75
Support 3 (S3) 4.61 4.93 4.70
Support 4 (S4) 4.57